Guggenheim

Venture capital firm

Is this your firm? Get featured or correct your listing →

We track Guggenheim but have little verified detail yet.

Latest Pulse

  1. BlossomHill Files for $100M Nasdaq IPO in Cancer DrugsBlossomHill Therapeutics filed for a $100M Nasdaq IPO under ticker BLSM, adding an oncology-focused biotech with $257M in prior funding to a summer pipeline of clinical-stage listings led by J.P. Morgan, Leerink and Guggenheim.→